Reuters logo
BRIEF-Ziopharm Oncology reports third quarter financial results
November 6, 2017 / 9:51 PM / 11 days ago

BRIEF-Ziopharm Oncology reports third quarter financial results

Nov 6 (Reuters) - Ziopharm Oncology Inc

* Ziopharm Oncology reports third quarter 2017 financial results and provides update on recent activities

* Q3 loss per share $0.13

* Q3 earnings per share view $-0.14 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below